Carl Cachia's  Instablog

Carl Cachia
Send Message
I work in the medical and healthcare field so my focus is mainly on Biotech stocks. I try to find the next Celgene, the next Pharamcylics if possible. Been a trader and investor for 13 years. Love the game, and I hope you enjoy my articles on here. Good luck with your investments and I look... More
  • Is IRobot Corporation About To Take Off? 0 comments
    Jul 8, 2013 1:50 PM | about stocks: IRBT

    A stock that is coming consistently on our watchlist is iRobot Corporation (NASDAQ:IRBT). Fundamentally, the picture is a bright one and the stock has been on a huge uptrend. A period of consolidation might occur but the stock is poised for new highs anytime.

    The story

    IRBT designs and builds robots that as the company says "that makes a difference". The company designs products that have a place both in the home, in defense and security and lately also in the medical field. I believe the latest product (RP-VITA) in the medical field is one that will take the company to new levels.


    The RP-VITA is the first remote presence solution for patient care. The robot features state-of-the-art mapping and obstacle detection and avoidance technology, a simple iPad user interface for control and interaction and the ability to interface with diagnostic devices and access electronic medical records.

    (click to enlarge)

    The future for this product

    The future for IRBT is very exciting. There are a number of new products that will follow the potential of the RP-VITA.

    Adapted from

    (click to enlarge)

    These robots are being planned to be introduced in 2014. Potential applications include their use in security environments, material transportation, caregiver support, factory inspection and in mobile kiosks.

    Fundamental analysis

    The company is currently valued at $1.14b. The company has $137m in cash with 0 debt making the possibility of a secondary issuing of shares remote. The float is 27m, with a high 8.4% short.

    The latest earning report were stellar. Revenues came in at $106.2m, which was higher than what analysts were expecting. GAAP reported sales were also 8.6% higher than the prior-year quarter. Earnings per share came in at $0.30 which was $0.12 higher than what analysts were expecting.

    Technical analysis

    Weekly chart is a thing of beauty. A nice trend. Expect this to continue going forward.

    (click to enlarge)


    There are a number of factors that makes IRBT a strong buy, even after this huge rise. There is improvement of gross margins, strategic alliances with big companies (Read here) and extensive and new product line make IRBT a stock to own for the future. I will continue to add on any dips in prices.

    Disclosure: I have no positions in any stocks mentioned, but may initiate a long position in IRBT over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

    Stocks: IRBT
Back To Carl Cachia's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.